Back to Journals » OncoTargets and Therapy » Volume 13

RETRACTED ARTICLE: A Circular RNA Derived from Golgi Glycoprotein 1 mRNA Regulates KRAS Expression and Promotes Colorectal Cancer Progression by Targeting microRNA-622

Authors Hao S, Qu R, Hu C, Wang M, Li Y

Received 26 September 2020

Accepted for publication 29 November 2020

Published 8 December 2020 Volume 2020:13 Pages 12637—12648

DOI https://doi.org/10.2147/OTT.S284032

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Takuya Aoki



This article has been retracted

Read the retraction statement published online on 31/01/2026

This paper has been retracted.

Hao S, Qu R, Hu C, Wang M, Li Y. Onco Targets Ther. 2020;13:12637–12648. https://doi.org/10.2147/OTT.S284032

We, the Editors and Publisher of the journal OncoTargets and Therapy, have retracted the published article.

After publication, concerns have been raised by a third party about the integrity of the data in Figures 2 and 3 of the article.

Further investigation conducted by the Journal and Publisher confirmed duplicate image panels representative of different treatment conditions present in Figures 2 and 3.

When approached for an explanation, the authors have provided their raw data and the relevant documentation. However, further data integrity concerns have been identified in the raw data provided.

As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.